Morphisec provides preemptive endpoint security using Automated Moving Target Defense to stop 100% of ransomware attacks at the endpoint. The platform prevents infiltration, protects against data encryption and system tampering, and enables rapid recovery. It integrates with existing EDR solutions and is used by organizations across finance, healthcare, and manufacturing.
Prevent ransomware attacks on Windows and Linux endpoints; Stop data encryption and system recovery tampering; Protect against credential theft; Recover encrypted files with forensic data; Close security gaps in EDR solutions
CrowdStrike: Acquired Adaptive Shield for approximately $300 million to enhance its Falcon cybersecurity platform. (6 months ago)
SentinelOne: Acquired Attivo Networks for $616.5 million to bolster its identity security capabilities. (2 weeks ago)
Fortinet:
Check Point Software: Acquired Cyberint to enhance its threat intelligence capabilities. (8 months ago)
Morphisec's key competitors and their key products or services are as follows:
CrowdStrike:
Microsoft Defender for Endpoint:
Sophos:
SentinelOne:
ESET:
Named a 4.8 on Gartner; 9M+ protected endpoints; 30K attacks addressed daily; 65% lower incident investigation costs; 30% cost reduction reported by clients; Protected 7K companies; Case studies with TruGreen, Merrick Bank, Bupa Latin America, Global hedge fund, Citizens Medical Center, Radwell, Yaskawa Motoman, Houston Eye Associates, PACCAR, Motorola